The Power of Mid-Sized Numbers
Executive Summary
Not so long ago, the mid-sized American drug company was a rare bird indeed. Thanks to its flexibility, it's now off the endangered list. The overvalued Big Pharmas, caught in their own tightening circles of strategic options, would do well to pay attention.